Literature DB >> 11751474

SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001.

F Liu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751474

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  13 in total

1.  TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis.

Authors:  Daniel R Principe; Brian DeCant; Emman Mascariñas; Elizabeth A Wayne; Andrew M Diaz; Naomi Akagi; Rosa Hwang; Boris Pasche; David W Dawson; Deyu Fang; David J Bentrem; Hidayatullah G Munshi; Barbara Jung; Paul J Grippo
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

Review 2.  Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.

Authors:  Julian Swierczynski; Areta Hebanowska; Tomasz Sledzinski
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: molecular cloning, expression, and in vitro characterization.

Authors:  Arghya Paul; Barbara A Jardin; Arun Kulamarva; Meenakshi Malhotra; Cynthia B Elias; Satya Prakash
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

4.  DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics.

Authors:  Sang Hyun Choi; Hyoung Jung Kim; Kyung Won Kim; Soyeon An; Seung-Mo Hong; Song Cheol Kim; Myung-Hwan Kim
Journal:  Br J Radiol       Date:  2017-03-24       Impact factor: 3.039

Review 5.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

6.  Advanced Proteogenomic Analysis Reveals Multiple Peptide Mutations and Complex Immunoglobulin Peptides in Colon Cancer.

Authors:  Sunghee Woo; Seong Won Cha; Stefano Bonissone; Seungjin Na; David L Tabb; Pavel A Pevzner; Vineet Bafna
Journal:  J Proteome Res       Date:  2015-07-21       Impact factor: 4.466

7.  Inhibition of pancreatic carcinoma cell growth in vitro by DPC4 gene transfection.

Authors:  Wei Shen; Guo-Qing Tao; De-Chun Li; Xing-Guo Zhu; Xia Bai; Bing Cai
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

8.  Infrequent alteration of the DPC4 tumor suppressor gene in renal cell carcinoma.

Authors:  Marijana Popović Hadzija; Reno Hrasćan; Maja Herak Bosnar; Zarko Zeljko; Mirko Hadzija; Josip Cadez; Kresimir Pavelić; Sanja Kapitanović
Journal:  Urol Res       Date:  2004-04-24

9.  DNAJA1 Dysregulates Metabolism Promoting an Antiapoptotic Phenotype in Pancreatic Ductal Adenocarcinoma.

Authors:  Heidi E Roth; Fatema Bhinderwala; Rodrigo Franco; You Zhou; Robert Powers
Journal:  J Proteome Res       Date:  2021-07-15       Impact factor: 4.466

10.  RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer.

Authors:  Hua Jiang; Chengzhi He; Shasha Geng; Haihui Sheng; Xiaoying Shen; Xiaoyan Zhang; Hang Li; Shizhang Zhu; Ximei Chen; Changqing Yang; HengJun Gao
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.